Overview
Positron emission tomography uses radiotracers to image metabolic activity. It provides functional information about tissues. It is often combined with CT or MRI for localization.
Clinical Applications
PET is used in oncology neurology and cardiology. It detects metabolic activity of tumors and brain disorders. It guides therapy selection and response assessment.
Radiotracers
Common tracers include FDG and others for specific targets. Tracer selection depends on clinical question. Radiochemistry advances expand tracer availability.
Hybrid Imaging
PET CT and PET MRI combine functional and anatomic data. These hybrids improve diagnostic accuracy and staging. They are valuable in complex cases.